Akoya Biosciences, Inc.
NASDAQ:AKYA
3.19 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 96.633 | 74.859 | 54.917 | 42.443 | 42.236 |
| Cost of Revenue
| 48.395 | 31.469 | 20.699 | 16.535 | 17.573 |
| Gross Profit
| 48.238 | 43.39 | 34.218 | 25.908 | 24.663 |
| Gross Profit Ratio
| 0.499 | 0.58 | 0.623 | 0.61 | 0.584 |
| Reseach & Development Expenses
| 21.889 | 23.211 | 15.701 | 9.603 | 8.761 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 25.451 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0.9 |
| SG&A
| 82.381 | 79.653 | 51.016 | 23.982 | 26.351 |
| Other Expenses
| -0.343 | 6.734 | 4.726 | 3.815 | 3.055 |
| Operating Expenses
| 104.27 | 109.598 | 71.443 | 37.4 | 38.167 |
| Operating Income
| -56.032 | -66.208 | -37.225 | -11.492 | -13.504 |
| Operating Income Ratio
| -0.58 | -0.884 | -0.678 | -0.271 | -0.32 |
| Total Other Income Expenses Net
| -7.251 | -4.31 | -5.85 | -5.172 | -1.053 |
| Income Before Tax
| -63.283 | -70.518 | -43.075 | -16.664 | -14.557 |
| Income Before Tax Ratio
| -0.655 | -0.942 | -0.784 | -0.393 | -0.345 |
| Income Tax Expense
| 0.04 | 0.123 | -0.14 | 0.042 | 0.194 |
| Net Income
| -63.323 | -70.641 | -42.935 | -16.706 | -14.751 |
| Net Income Ratio
| -0.655 | -0.944 | -0.782 | -0.394 | -0.349 |
| EPS
| -1.43 | -1.87 | -1.15 | -0.45 | -0.4 |
| EPS Diluted
| -1.43 | -1.87 | -1.15 | -0.45 | -0.4 |
| EBITDA
| -47.142 | -59.332 | -32.909 | -7.638 | -10.822 |
| EBITDA Ratio
| -0.488 | -0.793 | -0.599 | -0.18 | -0.256 |